Britt Christensen - Concepedia

Author

Britt Christensen

Also Known As

, B Christensen, B. CHR. CHRISTENSEN, B. Chr. Christensen, B. Christensen, B.Chr. Christensen, Britt Christensen, CHRISTENSEN, BRITT, britt Christensen

199

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

The Royal Melbourne Hospital Monash University The University of Melbourne University of Chicago St Vincent's Hospital Melbourne

About

Britt Christensen is an author at The Royal Melbourne Hospital specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	659
2	Social Sciences	3	3	52
3	Arts	2	2	31
4	Communication	2	2	31
5	Cell Biology	1	1	29

Britt Christensen

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes Britt Christensen, Stephen B. Hanauer, Jonathan M. Erlich, Clinical Gastroenterology and Hepatology Histologic Normalization OccursHistopathologyGastroenterologyPathologyClinical Gastroenterology	2017	231
Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting David T. Rubin, María T. Abreu, Victoria Rai, Gastroenterology	2020	201
Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn’s Disease Kerri L. Novak, Kim Nylund, Christian Maaser, Journal of Crohn s and Colitis	2020	201
Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn’s Disease than Endoscopic Healing Britt Christensen, Jonathan M. Erlich, Peter R. Gibson, Clinical Gastroenterology and Hepatology GastroenterologyPathologyEndoscopic HealingClinical OutcomesSurgery	2019	92
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease Britt Christensen, Peter R. Gibson, Dejan Micić, Clinical Gastroenterology and Hepatology Gastrointestinal PharmacologyPharmacologyGastroenterologyCombination TreatmentPharmacotherapy	2018	89
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease Britt Christensen, Dejan Micić, Peter G. Gibson, Alimentary Pharmacology & Therapeutics	2018	83
Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn’s disease Thomas M Goodsall, Vipul Jairath, Brian G. Feagan, Alimentary Pharmacology & Therapeutics	2021	66
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial Julien D. Schulberg, Emily K. Wright, Bronte A. Holt, The Lancet. Gastroenterology & hepatology Gastrointestinal PharmacologyGastroenterologyTherapeutic ControversyClinical GastroenterologyPharmacotherapy	2021	59
Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid‐refractory ulcerative colitis Jacob E. Ollech, Sujaata Dwadasi, Victoria Rai, Alimentary Pharmacology & Therapeutics	2019	53
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure Emma Flanagan, Peter R. Gibson, Emily K. Wright, Alimentary Pharmacology & Therapeutics	2020	52

Page 1